Last updated on: 22/06/2018
1. Contact details
Name of data sourceHospital Information System
Name under which the data source should be displayed in the inventory (e.g short name if one exists)HIS
Name of organisation
1) Department/research groupClinical Epidemiological Unit
2) Organisation/affiliationDepartment of Epidemiology
Administrative Contact
Title Dr
Last name Davoli
First name Marina
Address line 1Via Cristoforo Colombo 112
Address line 2
Address line 3
CityRome
Postcode00147
CountryItaly
Scientific Contact
Title Dr
Last name Davoli
First name Marina
Address line 1Via Cristoforo Colombo 112
Address line 2
Address line 3
CityRome
Postcode00147
CountryItaly
Alternative Contact
Title Mrs
Last name Kirchmayer
First name Ursula
Address line 1Via Cristoforo Colombo 112
Address line 2
Address line 3
CityRome
Postcode00147
CountryItaly
2. Description/category
Administrative database, e.g. claims database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
None
3.2 ATC code (5th level)
No
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
No events
5. Year of establishment
1996
6. Geographical origin of data
EEA/EFTA countries
Italy
7. Demographical extent of data collection
Regional sub-set :
Lazio region
8. Age groups
17 years and under [Paediatrics]
18 to 45 years
46 to 64 years
65 years and over
9. Size of the source/catchment population
5,700,000
10 a. Total (cumulative) number of persons with actual data
10 b. Number of persons with active data collection in past calendar year
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
record linkage can be performed with all other available information systems (MIS, PHARM, HEIS) using the individual patient code
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Di Domenicantonio R, Trotta F, Cascini S, Agabiti N, Kohn A, Gasbarrini A, Davoli M, Addis A. Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease. Clin Epidemiol. 2018 Feb 5;10:203-213. doi: 10.2147/CLEP.S150030. eCollection 2018.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804123/
Bettiol A, Lucenteforte E, Vannacci A, Lombardi N, Onder G, Agabiti N, Vitale C, Trifirò G, Corrao G, Roberto G, Mugelli A, Chinellato A; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE). Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly. Clin Drug Investig. 2017 Dec;37(12):1165-1174. doi: 10.1007/s40261-017-0576-2.
Colais P, Agabiti N, Davoli M, Buttari F, Centonze D, De Fino C, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, Bargagli A; Multiple Sclerosis Study Group, Lazio Region.
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy. Neuroepidemiology. 2017;48(3-4):171-178. doi: 10.1159/000479515. Epub 2017 Aug 9.
Colais P, Agabiti N, Fusco D, Pinnarelli L, Sorge C, Perucci CA, Davoli M.Inequality in 30-day mortality and the wait for surgery after hip fracture: the impact of the regional health care evaluation program in Lazio (Italy).Int J Qual Health Care. 2013 Jan 18
Cacciani L, Agabiti N, Bargagli AM, Davoli M. Access to percutaneous transluminal coronary angioplasty and 30-day mortality in patients with incident STEMI: Differentials by educational level and gender over 11 years. PLoS One. 2017 Apr 6;12(4):e0175038. doi: 10.1371/journal.pone.0175038. eCollection 2017.
